Greenwood Capital Associates’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-6,981
| Closed | -$317K | – | 228 |
|
2018
Q2 | $317K | Buy |
6,981
+1,408
| +25% | +$63.9K | 0.07% | 132 |
|
2018
Q1 | $294K | Sell |
5,573
-32
| -0.6% | -$1.69K | 0.07% | 140 |
|
2017
Q4 | $381K | Buy |
5,605
+996
| +22% | +$67.7K | 0.09% | 133 |
|
2017
Q3 | $380K | Sell |
4,609
-876
| -16% | -$72.2K | 0.09% | 125 |
|
2017
Q2 | $514K | Buy |
5,485
+212
| +4% | +$19.9K | 0.13% | 104 |
|
2017
Q1 | $336K | Sell |
5,273
-1,995
| -27% | -$127K | 0.09% | 135 |
|
2016
Q4 | $323K | Buy |
+7,268
| New | +$323K | 0.09% | 127 |
|